When you're a STAT+ subscriber, you get discounts on our STAT Reports and events, free access to premium data tools like our Obesity Drug Tracker, as well as in-depth daily coverage and analysis of the life sciences.
January 8, 2024, 6:00 p.m. – 9:00 p.m. PST | San Francisco, CA
Join STAT's biotech team in San Francisco as they take the stage to help you digest all the biggest stories from the year's biggest investor conference. Expect several surprise guests to stop by as well, to react to the latest happenings in nearby Union Square at the J.P. Morgan Healthcare Conference. Drinks and light bites will be served.
STAT+ Subscriber Exclusive: STAT will be hosting a workspace just steps away from the heart of Union Square during the week of the J.P. Morgan Healthcare Conference. Free coffee, snacks, and wifi will be provided.
Interpreting clinical trial results is not for the faint of heart. This report addresses the critical issue of spin in clinical trials. It emphasizes the need for vigilance when evaluating such trials' results, as misleading information can be concealed beneath apparently positive findings. But there is an art to reading and writing scientific findings — and you can learn it.
December 4, 2023, 6:00 p.m. – 9:00 p.m. EDT | Convene, 237 Park Ave, NY
Take a look back at the biggest buzz in biotech and pharma over the past year. STAT's leading reporters will take the stage alongside some of the biggest newsmakers of the year to reflect on big breakthroughs, unexpected challenges, and ultimate tales of success. They'll also share their predictions for the year ahead as the industry prepares for the JPM conference.
STAT+ subscribers can unlock a free ticket to this event.
December 19, 2023, 1:00 p.m. – 2:00 p.m. EDT | Virtual Since the development of Gleevec two decades ago, precision cancer medicines have become a driving force in biotech and a source of hope for cancer patients. Join STAT's Adam Feuerstein and our panel of experts as they discuss what has worked best, what hasn't, and the hottest new approaches in precision cancer medicines, including antibody drug conjugates, radiopharmaceuticals, tyrosine kinase inhibitors, and more.
-jpg.jpeg?width=420&upscale=true&name=biotech-job-market-blue-bright-1600x900%20(1)-jpg.jpeg)
No comments